These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34541915)

  • 1. A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients.
    Gasparini G; Canepa P; Verdiani S; Carmisciano L; Cozzani E; De Grazia D; Andrea O; Icardi G; Parodi A
    Int J Immunopathol Pharmacol; 2021; 35():20587384211042115. PubMed ID: 34541915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
    Borghi MO; Beltagy A; Garrafa E; Curreli D; Cecchini G; Bodio C; Grossi C; Blengino S; Tincani A; Franceschini F; Andreoli L; Lazzaroni MG; Piantoni S; Masneri S; Crisafulli F; Brugnoni D; Muiesan ML; Salvetti M; Parati G; Torresani E; Mahler M; Heilbron F; Pregnolato F; Pengo M; Tedesco F; Pozzi N; Meroni PL
    Front Immunol; 2020; 11():584241. PubMed ID: 33178218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
    Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
    J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
    Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IgA Isotype of Anti-β2 Glycoprotein I Antibodies Recognizes Epitopes in Domains 3, 4, and 5 That Are Located in a Lateral Zone of the Molecule (L-Shaped).
    Serrano M; Martinez-Flores JA; Norman GL; Naranjo L; Morales JM; Serrano A
    Front Immunol; 2019; 10():1031. PubMed ID: 31134087
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical analysis of anti-cardiolipin.beta 2 glycoprotein 1 antibody positive patients in anti-phospholipid syndrome.
    Katayama I; Nishioka K; Otoyama K
    J Dermatol Sci; 1995 May; 9(3):215-20. PubMed ID: 8664220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Serbian Primary Antiphospholipid Syndrome Patients Confirmed a Strong Association Between Livedo Reticularis and Arterial Thrombosis: A National Cross-Sectional Cohort Study.
    Djokovic A; Stojanovich L; Stanisavljevic N; Matic P; Colic D; Skrijelj D; Djokic S; Filipovic B
    J Clin Rheumatol; 2022 Oct; 28(7):362-366. PubMed ID: 35697016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
    Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
    Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
    Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
    Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-vimentin/cardiolipin IgA in the anti-phospholipid syndrome: A new tool for 'seronegative' diagnosis.
    Capozzi A; Riitano G; Mancuso S; Recalchi S; Manganelli V; Garofalo T; Alessandri C; Longo A; Misasi R; Conti F; Truglia S; Sorice M
    Clin Exp Immunol; 2021 Sep; 205(3):326-332. PubMed ID: 34107056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19.
    Zuo Y; Estes SK; Ali RA; Gandhi AA; Yalavarthi S; Shi H; Sule G; Gockman K; Madison JA; Zuo M; Yadav V; Wang J; Woodard W; Lezak SP; Lugogo NL; Smith SA; Morrissey JH; Kanthi Y; Knight JS
    Sci Transl Med; 2020 Nov; 12(570):. PubMed ID: 33139519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
    Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
    Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.
    Pérez D; Stojanovich L; Naranjo L; Stanisavljevic N; Bogdanovic G; Serrano M; Serrano A
    Front Immunol; 2018; 9():2644. PubMed ID: 30524428
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
    Foret T; Dufrost V; Salomon Du Mont L; Costa P; Lefevre B; Lacolley P; Regnault V; Zuily S; Wahl D
    Curr Rheumatol Rep; 2021 Jul; 23(8):65. PubMed ID: 34218350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations?
    Kontic M; Stojanovich L; Mijailović-Ivković M; Velinović M; Srnka J; Zdravkovic M
    Clin Exp Rheumatol; 2018; 36(1):56-61. PubMed ID: 28770705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.